According to the statement made by the European Union’s (EU) drug regulator, the European Medicines Agency (EMA), the “ABV5300” batch of vaccines produced by AstraZeneca against the new type of corona virus (Covid-19) caused blood clotting and caused the death of a person. It was reminded that it was discontinued due to causing pulmonary embolism.
It was reported that the person with pulmonary embolism was in the recovery phase.
“There is currently no indication that vaccination is the cause of these conditions, which are not listed among the side effects of these vaccines,” the statement said. statement took place.
In European countries, 22 cases of coagulation were reported in 3 million people with AstraZeneca vaccine as of 9 March.
In the EMA statement, it was emphasized that there is no information that the cases of vascular occlusion due to coagulation are seen more in people who have been vaccinated than in people who have not been vaccinated.
It was shared that it was not considered possible to have a quality defect in the aforementioned batch of vaccines, but the vaccines in this party were examined.
Batch number ABV5300, consisting of 1 million doses, was sent to 17 EU countries. The use of vaccines was also stopped as a precautionary measure in Estonia, Lithuania, Latvia and Luxembourg as of 9 March.